The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data
  • No CSPEC related information was provided by the message!
  • No CSPEC computed assertion could be determined for this classification!

  • See Evidence submitted by expert panel for details.

Variant: NM_000527.5(LDLR):c.1516G>A (p.Val506Met)

CA034649

251881 (ClinVar)

Gene: LDLR
Condition: hypercholesterolemia, familial
Inheritance Mode: Semidominant inheritance
UUID: 60f79a3e-a1ff-4f07-a491-924658759805
Approved on: 2024-02-23
Published on: 2024-09-25

HGVS expressions

NM_000527.5:c.1516G>A
NM_000527.5(LDLR):c.1516G>A (p.Val506Met)
NC_000019.10:g.11113692G>A
CM000681.2:g.11113692G>A
NC_000019.9:g.11224368G>A
CM000681.1:g.11224368G>A
NC_000019.8:g.11085368G>A
NG_009060.1:g.29312G>A
ENST00000252444.10:c.1774G>A
ENST00000559340.2:c.1516G>A
ENST00000560467.2:c.1396G>A
ENST00000558518.6:c.1516G>A
ENST00000252444.9:c.1770G>A
ENST00000455727.6:c.1012G>A
ENST00000535915.5:c.1393G>A
ENST00000545707.5:c.1135G>A
ENST00000557933.5:c.1516G>A
ENST00000558013.5:c.1516G>A
ENST00000558518.5:c.1516G>A
ENST00000559340.1:c.237G>A
NM_000527.4:c.1516G>A
NM_001195798.1:c.1516G>A
NM_001195799.1:c.1393G>A
NM_001195800.1:c.1012G>A
NM_001195803.1:c.1135G>A
NM_001195798.2:c.1516G>A
NM_001195799.2:c.1393G>A
NM_001195800.2:c.1012G>A
NM_001195803.2:c.1135G>A

Uncertain Significance

Met criteria codes 1
PP3
Not Met criteria codes 21
PVS1 BS2 BS4 BS3 BS1 BP2 BP3 BP4 PM6 PM2 PM3 PM1 PM4 PM5 PS2 PS4 PS3 PS1 PP4 PP1 BA1

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
Familial Hypercholesterolemia VCEP
The NM_000527.5(LDLR):c.1516G>A (p.Val506Met) variant is classified as Uncertain significance - insufficient evidence for Familial Hypercholesterolemia by applying ACMG/AMP evidence code PP3 as defined by the ClinGen Familial Hypercholesterolemia Expert Panel LDLR-specific variant curation guidelines (specification version 1.2) on 23 February 2024. The supporting evidence is as follows: PP3: REVEL=0.757.
Met criteria codes
PP3
REVEL=0.757. It is above 0.75, so PP3 is met.
Not Met criteria codes
PVS1
Not a null variant (nonsense, frameshift, canonical +/- 1 or 2 splice sites, initiation codon, single or multiexon deletion)
BS2
No data available.
BS4
No data available.
BS3
No data available.
BS1
FAF = 0.0004174 (0.04174%) in East Asian exomes (gnomAD v2.1.1).
BP2
No data available.
BP3
No in-frame deletions/insertions
BP4
REVEL=0.757. It is above 0.5
PM6
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PM2
PopMax MAF = 0.00071 (0.071%) in East Asian exomes+genomes (gnomAD v2.1.1).
PM3
No data available.
PM1
Variant doesn't meet PM2, is not on exon 4, and is not a cysteine residue.
PM4
No in-frame deletions/insertions
PM5
1 other missense variants in the same codon: - NM_000527.5(LDLR):c.1516G>C (p.Val506Leu) (ClinVar ID 926176) - Uncertain significance by these guidelines There is no variant in the same codon classified as Pathogenic by these guidelines.
PS2
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PS4
Variant doesn't meet PM2.
PS3
No data available.
PS1
No other missense variant with the same amino acid change
PP4
Variant doesn't meet PM2.
PP1
No data available.
BA1
FAF = 0.0004174 (0.04174%) in East Asian exomes (gnomAD v2.1.1).
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.